NeoImmuneTech (XKRX:950220) Pre-Tax Income : ₩-53,007.71 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is NeoImmuneTech Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. NeoImmuneTech's pretax income for the three months ended in Dec. 2023 was ₩-11,793.27 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-53,007.71 Mil. NeoImmuneTech's pretax margin was %.

NeoImmuneTech Pre-Tax Income Historical Data

The historical data trend for NeoImmuneTech's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoImmuneTech Pre-Tax Income Chart

NeoImmuneTech Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

-14,192.84

-30,428.95

-52,412.87

-60,289.21

-53,303.21

NeoImmuneTech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial											-2,647.31	-11,737.75	-16,422.38	-13,054.31	-11,793.27

Competitive Comparison of NeoImmuneTech's Pre-Tax Income

For the Biotechnology subindustry, NeoImmuneTech's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeoImmuneTech's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NeoImmuneTech's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where NeoImmuneTech's Pre-Tax Income falls into.

NeoImmuneTech Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

NeoImmuneTech's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-55617.962	+	0	+	-225.28	+	2876.548	+	-336.51700000001
	=	-53,303.21

NeoImmuneTech's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-13204.788	+	0	+	-55.47	+	763.704	+	703.284
	=	-11,793.27

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-53,007.71 Mil.

NeoImmuneTech (XKRX:950220) Pre-Tax Income Explanation

NeoImmuneTech's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-11793.27	/	0
	=	%

NeoImmuneTech Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of NeoImmuneTech's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

NeoImmuneTech (XKRX:950220) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeoImmuneTech Inc (XKRX:950220) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

2400 Research Boulevard, Suite 250, Rockville, MD, USA, 20850

Website

http://www.neoimmunetech.com

NeoImmuneTech Inc is a clinical-stage T cell-focused biotech company dedicated to the discovery and development of novel immuno-therapeutics. Its lead asset NT-I7 is the clinical stage IL-7, which enhances the body's immune function to address key resistance mechanisms in Immuno-Oncology and deadly infectious diseases.

NeoImmuneTech (XKRX:950220) Headlines

No Headlines